PAR 14.3% 20.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-89

  1. 269 Posts.
    lightbulb Created with Sketch. 24
    I don't think PR would survive another capital raise if it were at or below the recent 43c raise, as evidenced by the recent agreement with Scott Williams. He'd be well aware of this.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.